MarketView

MarketView

RXA MarketView enables pharmaceutical companies to analyse the current prescribing of a new or potential product and help to develop a market entry strategy.

The tool provides comprehensive analysis for both NHS and pharmaceutical companies of the UK prescribing market, giving valuable insight down to CCG level.

With the RXA MarketView tool you can:

  • Analyse up to 5 years of NHS prescribing and other sales data
  • See data for all 20,000+ products prescribed by UK GPs, including branded and generic products
  • See data for England, Wales, Scotland and Northern Ireland
  • Select a range of reporting dimensions and filters
    • SHA
    • Area/CCG
    • GP Practice
    • Product
    • Brand vs. Generic
  • View extensive highly visual tables, charts and maps in the purpose-built dashboard
  • Access easy to interpret analytics
  • Export all data and graphics for ad-hoc analytics and report building – (E.g. Excel, CSV, jpeg and PDF)
We make analytics simple
Request your demonstration today

“Working with Inspiremed is a great partnership experience and they make sure they understand your business, the industry that you are in and what you want to achieve in the use of the product.”

National Sales Manager, UK Pharmaceutical Company

“Inspiremed are a pleasure to work with, blending both a solid understanding of software development and commercial experience.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“Key benefits? Adaptability, flexibility for future changes and cloud-based.”

General Manager, Global Healthcare Company

“The feature I like most? The ability to drill down to competitor sales.”

Senior Manager, Global Healthcare Company, 2016

“The level of analysis and insight gained from use of Rx Analyser is non-comparable. Customer segmentation, targeting and development of compelling value propositions is much more straightforward.”

Sales and Marketing Manager, Leading Healthcare Company, 2016

“Customers tell us our platform has changed the way they work, that they’ve enhanced the strategies they implement, based on the work they’ve done with the analyser tool and that – bottom line – we’ve helped them to increase their sales. That’s a pretty good result from a chance cup of coffee.”

Andrew Norman and David Warwick, Directors

Sign up for added insights